Michaela U Gack Selected Research

Hepatitis C

1/2018

Identification of a second binding site on the TRIM25 B30.2 domain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michaela U Gack Research Topics

Disease

13	Infections 05/2024 - 12/2013
13	Virus Diseases (Viral Diseases) 12/2023 - 04/2007
10	COVID-19 01/2023 - 01/2020
3	RNA Virus Infections 04/2024 - 04/2007
3	Neoplasms (Cancer) 01/2021 - 01/2019
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019 - 05/2015
2	Inflammation (Inflammations) 01/2023 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2020 - 07/2020
2	Crohn Disease (Crohn's Disease) 11/2020 - 07/2020
2	Human Influenza (Influenza) 01/2018 - 01/2012
1	Myocarditis (Carditis) 05/2024
1	Carcinogenesis 02/2024
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 11/2022
1	Common Variable Immunodeficiency 11/2022
1	Vesicular Stomatitis 01/2022
1	DNA Virus Infections 01/2022
1	Persistent Infection 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Progressive Multifocal Leukoencephalopathy 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Herpesviridae Infections (Herpesvirus Infection) 01/2019
1	Hepatitis C 01/2018
1	Viremia 01/2015
1	Hepatitis 09/2014
1	Measles 07/2014
1	Hypoxia (Hypoxemia) 03/2008
1	Pathologic Neovascularization 03/2008
1	Lymphoma (Lymphomas) 10/2006

Drug/Important Bio-Agent (IBA)

21	Antiviral Agents (Antivirals)IBA 05/2024 - 04/2007
14	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2015
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2012
8	Interferon Type IIBA 05/2024 - 04/2007
4	InterferonsIBA 12/2023 - 04/2007
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 04/2007
4	Viral RNAIBA 01/2019 - 04/2007
3	CytokinesIBA 12/2023 - 01/2019
3	UbiquitinIBA 12/2023 - 01/2012
3	VaccinesIBA 01/2023 - 10/2020
3	Pattern Recognition ReceptorsIBA 01/2019 - 05/2015
3	Tripartite Motif ProteinsIBA 01/2018 - 10/2008
2	RNA Polymerase IIIIBA 01/2023 - 11/2022
2	A-Form DNA (A-DNA)IBA 01/2021 - 01/2018
2	PapainIBA 01/2021 - 10/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 10/2020
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019 - 09/2014
2	Nucleic AcidsIBA 01/2019 - 01/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019 - 12/2018
2	Ligases (Synthetase)IBA 12/2013 - 01/2012
1	CarbonIBA 02/2024
1	NucleotidesIBA 02/2024
1	Protein Isoforms (Isoforms)IBA 01/2023
1	AcetyltransferasesIBA 01/2023
1	Transcription Factor TFIIIAIBA 11/2022
1	LigandsIBA 11/2022
1	Protein Phosphatase 1IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Immediate-Early ProteinsIBA 12/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	EnzymesIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	FurinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	MelatoninIBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	triphosphoric acid (triphosphate)IBA 01/2018
1	5S Ribosomal RNAIBA 01/2018
1	Viral DNAIBA 05/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2015
1	FenretinideIBA 01/2015
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 07/2014
1	Phospho-Specific AntibodiesIBA 06/2010
1	Serine (L-Serine)FDA Link 06/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 03/2008
1	Oxygen (Dioxygen)IBA 03/2008
1	Oncogene Proteins (Oncogene Protein)IBA 10/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 07/2020
1	Immunotherapy 01/2019